Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:ACKNOWLEDGEMENT
Volume: 12 Issue: 4
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENT, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2012; 12 (4) . https://dx.doi.org/10.2174/187152212803521039
DOI https://dx.doi.org/10.2174/187152212803521039 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Article Metrics
Related Articles
-
Development of Controlled Release Osmotic Pump Tablet of Glipizide Solid Dispersion
Current Drug Delivery CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Biomaterials and Mesenchymal Stem Cells for Regenerative Medicine
Recent Patents on Biotechnology Protein-Energy Malnutrition Alters Thermoregulatory Homeostasis and the Response to Brain Ischemia
Current Neurovascular Research Heavy Metals and Epigenetic Alterations in Brain Tumors
Current Genomics Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry Nano-Sized Crystalline Drug Production by Milling Technology
Current Pharmaceutical Design Novel and Practical Approaches to Manage Diet-induced Metabolic Disorders: Part-I
Current Pharmaceutical Design Metformin and its Liver Targets in the Treatment of Type 2 Diabetes
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Current Medicinal Chemistry Lead Molecules as Novel Aromatase Inhibitors: In Silico De Novo Designing and Binding Affinity Studies
Letters in Drug Design & Discovery Neurovascular Signals Suggest a Propagation Mechanism for Endogenous Stem Cell Activation Along Blood Vessels
CNS & Neurological Disorders - Drug Targets The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases
Current Medicinal Chemistry Hypothalamus-Pituitary-Adrenal (HPA) Axis and Metabolic Abnormalities in First-Episode Psychosis
Current Psychiatry Reviews Pharmacokinetic Considerations of Perinatal Antiretroviral Therapy
Current Drug Metabolism Nasal Drug Delivery System-Factors Affecting and Applications
Current Drug Therapy Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Charcot Neuroarthropathy: From the Laboratory to the Bedside
Current Diabetes Reviews Emerging Risk Factors for Cerebrovascular Disease
Current Drug Targets Drug Loaded Erythrocytes: As Novel Drug Delivery System
Current Pharmaceutical Design